VA HB 831
Status unknownMedication, drug, and vaccine ingredient labeling; Board of Pharmacy, et al., to study.
Virginia · 2026 Regular Session · lower
Quick answers
Did VA HB 831 pass?
The current status of VA HB 831 is not known from the official record. Latest recorded action (2026-02-18): Left in Committee Rules
What is VA HB 831 about?
Board of Pharmacy; work group to study medication, drug, and vaccine ingredient labeling; report. Directs the Board of Pharmacy to convene a work group to study medication, drug, and vaccine ingredient labeling. The bill directs the work group to review all regulations related to medications, drugs, or vaccines sold or distributed in the Commonwealth to ensure that (i) all active and inactive ingredients contained in such medication, drug, or vaccine are clearly listed on the product packaging or accompanying informational insert and (ii) accompanying informational inserts are readily available to consumers at a pharmacy upon request. The bill also directs the work group to study and make recommendations on the feasibility of requiring that any medication, drug, or vaccine sold or distributed in the Commonwealth that includes gluten as an active or inactive ingredient include a statement on the packaging or insert that such product contains gluten. The bill requires the work group to report its findings and recommendations to the Chairs of the House Committee on Health and Human Services and the Senate Committee on Education and Health by December 1, 2026.
Who sponsors VA HB 831?
Hillary Pugh Kent is the primary sponsor of VA HB 831.
Description
Board of Pharmacy; work group to study medication, drug, and vaccine ingredient labeling; report. Directs the Board of Pharmacy to convene a work group to study medication, drug, and vaccine ingredient labeling. The bill directs the work group to review all regulations related to medications, drugs, or vaccines sold or distributed in the Commonwealth to ensure that (i) all active and inactive ingredients contained in such medication, drug, or vaccine are clearly listed on the product packaging or accompanying informational insert and (ii) accompanying informational inserts are readily available to consumers at a pharmacy upon request. The bill also directs the work group to study and make recommendations on the feasibility of requiring that any medication, drug, or vaccine sold or distributed in the Commonwealth that includes gluten as an active or inactive ingredient include a statement on the packaging or insert that such product contains gluten. The bill requires the work group to report its findings and recommendations to the Chairs of the House Committee on Health and Human Services and the Senate Committee on Education and Health by December 1, 2026.
- Introduced
- 2026-01-13
- Latest action
- 2026-02-18 — Left in Committee Rules
- Bill type
- bill
- Last updated
- —
Sponsors
- Hillary Pugh Kentprimary
Committees
Not provided by source.
Action timeline
2026-01-13
Prefiled and ordered printed; Offered 01-14-2026 26103422D
filing,introduction
2026-01-13
Referred to Committee on Rules
referral-committee
2026-01-22
Assigned HRUL sub: Studies Subcommittee
referral-committee
2026-01-23
House subcommittee offered
2026-01-23
Subcommittee recommends laying on the table (5-Y 0-N)
2026-02-18
Left in Committee Rules
Versions
Documents
Votes
Subcommittee recommends laying on the table
2026-01-23 · pass · 5-0
Member-level votes (5)
- Dan I. Helmer: yes
- Richard C. "Rip" Sullivan, Jr.: yes
- C.E. Cliff Hayes, Jr.: yes
- Kathy K.L. Tran: yes
- Terry G. Kilgore: yes
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:35:59.552682Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=VA&identifier=HB 831. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.